+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Analytical Testing Outsourcing Market by Service Type, Technology, Molecule Type, Application, End User, Project Duration - Global Forecast 2025-2030- Product Image
Pharmaceutical Analytical Testing Outsourcing Market by Service Type, Technology, Molecule Type, Application, End User, Project Duration - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Analytical Testing Outsourcing Market by Service Type, Technology, Molecule Type, Application, End User, Project Duration - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454989
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical analytical testing outsourcing market is evolving rapidly, offering specialized external expertise that enhances quality, compliance, and efficiency in drug development. Senior decision-makers now have access to advanced capabilities, innovative technologies, and scalable solutions in a sector increasingly defined by regulatory demands, molecular complexity, and strategic partnerships.

Market Snapshot: Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market grew from USD 10.07 billion in 2024 to USD 11.05 billion in 2025. It is expected to continue growing at a CAGR of 9.45%, reaching USD 17.32 billion by 2030. This robust trajectory is led by factors such as intensifying pipeline complexity, an increasing focus on regulatory compliance, and the drive for operational efficiency. The landscape presents significant opportunities for contract laboratories and sponsors to leverage next-generation analytical technologies and digital transformation, supporting fast-paced drug development cycles and risk mitigation.

Scope & Segmentation

  • Service Type: Bioanalytical Testing, Impurity Testing, Microbiological Testing, Stability Testing
  • Technology: Cell Based Assays, Chromatography (GC, HPLC including Ion Exchange, Reverse Phase, UHPLC), Mass Spectrometry (GC MS, LC MS MS, MALDI TOF), qPCR, Spectroscopy (FTIR, NMR, UV Vis)
  • Molecule Type: Biologic, Small Molecule
  • Application: Biosimilarity Assessment, Drug Discovery & Development, Quality Control
  • End User: Academic & Government Institutes, Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies
  • Project Duration: Long Term Projects, Short Term Projects

Geographical Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key countries include United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).

Featured Companies: Eurofins Scientific SE, SGS SA, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., WuXi AppTec Co., Ltd., Catalent, Inc., Intertek Group plc, Syneos Health, Inc., ICON plc.

Key Takeaways for Senior Decision-Makers

  • Advanced laboratory partnerships enable rapid access to high-throughput and precision analytical tools, freeing internal resources for core R&D integration.
  • Growing demand for complex drug modalities is driving adoption of innovative analytic platforms, supporting new therapeutic categories and molecular classes.
  • Digital transformation, including cloud-based management systems and AI-driven analytics, is improving data integrity and enabling real-time project oversight.
  • Enhanced regional collaboration and localized outsourcing models help sponsors navigate regulatory variability, supply chain uncertainties, and evolving compliance standards worldwide.
  • Sustainability considerations prompt laboratories to invest in energy-efficient equipment, green chemistry principles, and remote audit practices, aligning operations with global corporate responsibility trends.

Tariff Impact on Cost Structures and Sourcing Strategies

The upcoming United States tariffs scheduled for 2025 are set to influence cost structures by increasing prices for necessary instrumentation components, reagents, and consumables. Sponsors and contract laboratories are proactively adjusting procurement approaches, evaluating domestic sourcing, and considering strategic onshoring or nearshoring to manage cost volatility and maintain project timelines.

Strategic supplier negotiations and a renewed focus on multi-vendor partnerships are helping limit exposure, while investments in in-house production and technology diversification are emerging as key mitigation tactics.

Methodology & Data Sources

This report is based on interviews with senior industry stakeholders, extensive surveys of analytical service providers, and the analysis of leading industry publications and regulatory documents. Quantitative and qualitative methods were employed, and all findings were peer-reviewed for accuracy. Strict confidentiality and quality assurance measures were observed throughout the process.

Why This Report Matters

  • Senior leaders gain a clear understanding of evolving industry standards, enabling actionable planning around regulatory shifts and operational risk.
  • This analysis reveals strategic pathways in technology adoption, market entry, and partnership formation across regions and service offerings.
  • Organizations can benchmark strengths and opportunities against leading providers and make informed investment decisions in a dynamic global landscape.

Conclusion

The pharmaceutical analytical testing outsourcing market is undergoing significant change, shaped by innovation, regional diversification, and regulatory adaptation. Strategic investment and agile collaboration are essential for sustained growth and a resilient competitive position.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of high-resolution mass spectrometry for impurity profiling in complex biologics
5.2. Growing demand for automation and robotics in analytical workflows to reduce turnaround times
5.3. Expansion of stability testing services to support extended biologic shelf life and global distribution
5.4. Rising importance of digital chromatography data integrity solutions for regulatory compliance
5.5. Surge in demand for cGMP-compliant analytical method development for novel cell and gene therapies
5.6. Implementation of AI-driven spectral deconvolution tools to enhance small molecule identification
5.7. Shift toward integrated multi-omics analytics platforms for comprehensive drug safety assessments
5.8. Increased outsourcing of viral safety testing and adventitious agent screening in biopharma
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Analytical Testing Outsourcing Market, by Service Type
8.1. Introduction
8.2. Bioanalytical Testing
8.3. Impurity Testing
8.4. Microbiological Testing
8.5. Stability Testing
9. Pharmaceutical Analytical Testing Outsourcing Market, by Technology
9.1. Introduction
9.2. Cell Based Assays
9.3. Chromatography
9.3.1. GC
9.3.2. HPLC
9.3.2.1. Ion Exchange
9.3.2.2. Reverse Phase
9.3.3. UHPLC
9.4. Mass Spectrometry
9.4.1. GC MS
9.4.2. LC MS MS
9.4.3. MALDI TOF
9.5. qPCR
9.6. Spectroscopy
9.6.1. FTIR
9.6.2. NMR
9.6.3. UV Vis
10. Pharmaceutical Analytical Testing Outsourcing Market, by Molecule Type
10.1. Introduction
10.2. Biologic
10.3. Small Molecule
11. Pharmaceutical Analytical Testing Outsourcing Market, by Application
11.1. Introduction
11.2. Biosimilarity Assessment
11.3. Drug Discovery & Development
11.4. Quality Control
12. Pharmaceutical Analytical Testing Outsourcing Market, by End User
12.1. Introduction
12.2. Academic & Government Institutes
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
13. Pharmaceutical Analytical Testing Outsourcing Market, by Project Duration
13.1. Introduction
13.2. Long Term Projects
13.3. Short Term Projects
14. Americas Pharmaceutical Analytical Testing Outsourcing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Eurofins Scientific SE
17.3.2. SGS SA
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. Laboratory Corporation of America Holdings
17.3.5. Charles River Laboratories International, Inc.
17.3.6. WuXi AppTec Co., Ltd.
17.3.7. Catalent, Inc.
17.3.8. Intertek Group plc
17.3.9. Syneos Health, Inc.
17.3.10. ICON plc
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: RESEARCHAI
FIGURE 28. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: RESEARCHSTATISTICS
FIGURE 29. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: RESEARCHCONTACTS
FIGURE 30. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ION EXCHANGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ION EXCHANGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REVERSE PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REVERSE PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UHPLC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UHPLC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GC MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LC MS MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LC MS MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MALDI TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FTIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FTIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NMR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NMR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UV VIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY UV VIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOSIMILARITY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOSIMILARITY ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LONG TERM PROJECTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY LONG TERM PROJECTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SHORT TERM PROJECTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SHORT TERM PROJECTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 140. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 141. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 142. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 143. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 144. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 145. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 146. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 147. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PROJECT DURATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 264. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, 2025

Samples

Loading
LOADING...

Companies Mentioned

  • Eurofins Scientific SE
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.
  • Catalent, Inc.
  • Intertek Group plc
  • Syneos Health, Inc.
  • ICON plc

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.32 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmaceutical Analytical Testing Outsourcing - Global Strategic Business Report - Product Image

Pharmaceutical Analytical Testing Outsourcing - Global Strategic Business Report

  • Report
  • 112 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market by Type, Service, End User, and Region 2025-2033 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market by Type, Service, End User, and Region 2025-2033

  • Report
  • 134 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market 2024-2028 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market 2024-2028

  • Report
  • 145 Pages
  • Global
From
Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From

About the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing market is a subset of the Drug Discovery industry, which involves the development of new drugs and treatments. It is a highly specialized field that requires a range of analytical testing services to ensure the safety and efficacy of new drugs. Outsourcing these services to specialized companies can help reduce costs and speed up the drug development process. Analytical testing services include a range of activities such as method development and validation, stability testing, impurity profiling, and bioanalytical testing. These services are essential for ensuring the quality and safety of new drugs, and for meeting regulatory requirements. Companies in the Pharmaceutical Analytical Testing Outsourcing market include Eurofins Scientific, SGS, Intertek, Charles River Laboratories, and WuXi AppTec. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.